These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38965921)

  • 1. Skeletal Muscle Proteome Modifications following Antibiotic-Induced Microbial Disturbances in Cancer Cachexia.
    Simonson M; Cueff G; Thibaut MM; Giraudet C; Salles J; Chambon C; Boirie Y; Bindels LB; Gueugneau M; Guillet C
    J Proteome Res; 2024 Jul; 23(7):2452-2473. PubMed ID: 38965921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of adiponectin receptor agonist AdipoRon relieves cancer cachexia by mitigating inflammation in tumour-bearing mice.
    Massart IS; Kouakou AN; Pelet N; Lause P; Schakman O; Loumaye A; Abou-Samra M; Deldicque L; Bindels LB; Brichard SM; Thissen JP
    J Cachexia Sarcopenia Muscle; 2024 Jun; 15(3):919-933. PubMed ID: 38572511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A standardized herbal combination of Astragalus membranaceus and Paeonia japonica, protects against muscle atrophy in a C26 colon cancer cachexia mouse model.
    Lee SB; Lee JS; Moon SO; Lee HD; Yoon YS; Son CG
    J Ethnopharmacol; 2021 Mar; 267():113470. PubMed ID: 33068652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle and serum metabolomes are dysregulated in colon-26 tumor-bearing mice despite amelioration of cachexia with activin receptor type 2B ligand blockade.
    Lautaoja JH; Lalowski M; Nissinen TA; Hentilä J; Shi Y; Ritvos O; Cheng S; Hulmi JJ
    Am J Physiol Endocrinol Metab; 2019 May; 316(5):E852-E865. PubMed ID: 30860875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscle NAD
    Hulmi JJ; Penna F; Pöllänen N; Nissinen TA; Hentilä J; Euro L; Lautaoja JH; Ballarò R; Soliymani R; Baumann M; Ritvos O; Pirinen E; Lalowski M
    Mol Metab; 2020 Nov; 41():101046. PubMed ID: 32599075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cachexia induced by cancer and chemotherapy yield distinct perturbations to energy metabolism.
    Pin F; Barreto R; Couch ME; Bonetto A; O'Connell TM
    J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):140-154. PubMed ID: 30680954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quercetin Improved Muscle Mass and Mitochondrial Content in a Murine Model of Cancer and Chemotherapy-Induced Cachexia.
    VanderVeen BN; Cardaci TD; Cunningham P; McDonald SJ; Bullard BM; Fan D; Murphy EA; Velázquez KT
    Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid attenuates skeletal muscle wasting by inhibiting C/EBPβ-regulated atrogin1 expression in cancer cachexia.
    Sun R; Zhang S; Hu W; Lu X; Lou N; Yang Z; Chen S; Zhang X; Yang H
    Am J Physiol Cell Physiol; 2016 Jul; 311(1):C101-15. PubMed ID: 27122162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased insulin-like growth factor-1 expression in response to mechanical loading is associated with skeletal muscle anabolic resistance in cancer cachexia.
    Miyazaki M; Sawada A; Sawamura D; Yoshida S
    Growth Horm IGF Res; 2023; 69-70():101536. PubMed ID: 37229943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The mitochondrial metabolic reprogramming agent trimetazidine as an 'exercise mimetic' in cachectic C26-bearing mice.
    Molinari F; Pin F; Gorini S; Chiandotto S; Pontecorvo L; Penna F; Rizzuto E; Pisu S; Musarò A; Costelli P; Rosano G; Ferraro E
    J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):954-973. PubMed ID: 29130633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia.
    Silva KA; Dong J; Dong Y; Dong Y; Schor N; Tweardy DJ; Zhang L; Mitch WE
    J Biol Chem; 2015 Apr; 290(17):11177-87. PubMed ID: 25787076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-compartment metabolomics and metagenomics reveal major hepatic and intestinal disturbances in cancer cachectic mice.
    Pötgens SA; Thibaut MM; Joudiou N; Sboarina M; Neyrinck AM; Cani PD; Claus SP; Delzenne NM; Bindels LB
    J Cachexia Sarcopenia Muscle; 2021 Apr; 12(2):456-475. PubMed ID: 33599103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic analysis of the small extracellular vesicles and soluble secretory proteins from cachexia inducing and non-inducing cancer cells.
    Chitti SV; Kang T; Fonseka P; Marzan AL; Stewart S; Shahi S; Bramich K; Ang CS; Pathan M; Gummadi S; Mathivanan S
    Proteomics; 2023 Aug; 23(15):e2100314. PubMed ID: 37309723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Treatment with the Ghrelin Receptor Agonist HM01 Attenuates Cachexia in Mice Bearing Colon-26 (C26) Tumors.
    Villars FO; Pietra C; Giuliano C; Lutz TA; Riediger T
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28475119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomics analysis of C2C12 myotubes treated with atrophy inducing cancer cell-derived factors.
    Marzan AL; Chitti SV; Gummadi S; Kang T; Ang CS; Mathivanan S
    Proteomics; 2024 Jun; 24(11):e2300020. PubMed ID: 37882347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Females display relatively preserved muscle quality compared with males during the onset and early stages of C26-induced cancer cachexia.
    Cabrera AR; Deaver JW; Lim S; Morena da Silva F; Schrems ER; Saling LW; Tsitkanou S; Rosa-Caldwell ME; Wiggs MP; Washington TA; Greene NP
    J Appl Physiol (1985); 2023 Sep; 135(3):655-672. PubMed ID: 37535708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Voluntary exercise prevents abnormal muscle mitochondrial morphology in cancer cachexia mice.
    Kitaoka Y; Miyazaki M; Kikuchi S
    Physiol Rep; 2021 Aug; 9(16):e15016. PubMed ID: 34427401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerobic and resistance training dependent skeletal muscle plasticity in the colon-26 murine model of cancer cachexia.
    Khamoui AV; Park BS; Kim DH; Yeh MC; Oh SL; Elam ML; Jo E; Arjmandi BH; Salazar G; Grant SC; Contreras RJ; Lee WJ; Kim JS
    Metabolism; 2016 May; 65(5):685-698. PubMed ID: 27085776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumour-derived leukaemia inhibitory factor is a major driver of cancer cachexia and morbidity in C26 tumour-bearing mice.
    Kandarian SC; Nosacka RL; Delitto AE; Judge AR; Judge SM; Ganey JD; Moreira JD; Jackman RW
    J Cachexia Sarcopenia Muscle; 2018 Dec; 9(6):1109-1120. PubMed ID: 30270531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased hypoxia-inducible factor-1α in striated muscle of tumor-bearing mice.
    Devine RD; Bicer S; Reiser PJ; Wold LE
    Am J Physiol Heart Circ Physiol; 2017 Jun; 312(6):H1154-H1162. PubMed ID: 28341633
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.